BioSpace News Archive

Career Advice

How to Quit With Class: 13 Things Not to Do When You Quit a Job

“Quitting with class” means separating yourself from your current employer in such a way that you leave your professional reputation intact, keep those bridges unburnt, and even set yourself up for glowing recommendations (or even another future job offer?) from your employer.

September 3, 2018
·
5 min read
·
Editorial Staff
Business

Are Celgene Shares Ready for a Recovery?

It hasn’t been a particularly good year for Celgene. But, are company shares about to bounce back? Some analysts think so.

September 3, 2018
·
3 min read
·
Mark Terry
Business

Movers and Shakers for Sept. 4

Biopharm companies closed out August with a plethora of changes to executive and senior leadership positions. Let’s take a look.

September 3, 2018
·
5 min read
·
Alex Keown
Evox Therapeutics Completes £35.5 Million Series B Financing

Proceeds will advance transformative exosome therapeutics pipeline towards the clinic

September 3, 2018
·
3 min read
H&D Wireless Receives Norwegian Add-on Order

H&D Wireless receives add-on order of the new SPB228 Wi-Fi/BT module with a value of 41,000 USD.

September 3, 2018
·
3 min read
Sunstar Supports Release of Chairside Guide on Prevention and Treatment of Oral Cancer

Sunstar is proud to announce the launch of Oral Cancer: Prevention and patient management, an FDI World Dental Federation chairside guide for oral health professionals.

September 3, 2018
·
3 min read
Deals

Olon Acquires Manufacturing Facility in Mahad, India

Olon S.p.A. announced today the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.

September 3, 2018
·
3 min read
Pharm Country

Cablivi™ (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

The European Commission has granted marketing authorization for Cablivi™ (caplacizumab) for the treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood-clotting disorder.

September 3, 2018
·
6 min read
Business

NovellusDx and Primetech Sign an Exclusive Dealer Agreement in Japan

NovellusDx, Ltd. and Primetech Co., Ltd. announce that Primetech will provide NovellusDx’ functional genomics assay “FACT – Functional Annotation for Cancer Treatment” as an exclusive dealer in Japan for the pre-clinical market with sales, marketing and research support / technical support in Japan.

September 3, 2018
·
2 min read
Business

BioArctic Expands the Research Collaboration With Uppsala University Concerning Antibody-based Diagnostic Imaging of the Brain in Alzheimer Patients

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that the company has signed an expanded research collaboration agreement with Uppsala University, in Sweden, Department of Public Health and Caring Sciences, Molecular Geriatrics.

September 3, 2018
·
4 min read